Specifically, in breast cancer, VIM has been shown to prevent miR‐dependent negative regulation of tissue factor mRNA by interacting with its 3′‐UTR during EMTs of circulating tumor cells, promoting coagulant activity associated with early metastasis.14 This evidence concerns the gene F3 and breast carcinoma.